Dr Kuykendall discusses the FDA approval of momelotinib in myelofibrosis with anemia, key data from the MOMENTUM trial, and how momelotinib alters the myelofibrosis treatment paradigm.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
